In addition, high serum levels of sCD163 were reported as an independent predictor of shorter survival in hepatocellular carcinoma patients [22], and associated with poor prognosis in terms of shorter disease-free survival among patients with ovarian cancer [32]. Here, CD163 is linked to ovarian cancer.